Prime Medicine, Inc. Net Income

Net Income of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income growth rates and interactive chart. Net income (NI), also called net earnings, is calculated as sales minus cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes, and other expenses. It is the profit available to all shareholders, both preferred and common.

Highlights and Quick Summary

  • Net Income for the quarter ending September 30, 2023 was $-50.7 Million (a 19.64% increase compared to previous quarter)
  • Year-over-year quarterly Net Income increased by 29.08%
  • Annual Net Income for 2022 was $-122 Million (a -26.33% decrease from previous year)
  • Annual Net Income for 2021 was $-165 Million (a 4749.47% increase from previous year)
  • Annual Net Income for 2020 was $-3.41 Million (a 34.84% increase from previous year)
  • Twelve month Net Income ending September 30, 2023 was $-172 Million (a 14.2% increase compared to previous quarter)
  • Twelve month trailing Net Income increased by 41.0% year-over-year
Trailing Net Income for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
$-172 Million $-150 Million $-137 Million $-122 Million
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income of Prime Medicine, Inc.

Most recent Net Incomeof PRME including historical data for past 10 years.

Interactive Chart of Net Income of Prime Medicine, Inc.

Prime Medicine, Inc. Net Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-50.71 $-42.39 $-39.4 – –
2022 $-39.28 $-29.35 $-29.35 $-23.84 $-121.82
2021 – – $-62.91 $-102.46 $-165.37
2020 – – – $-3.41 $-3.41
2019 – – – – $-2.53

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com